-transparent.png){kind=logo}
Mutations in the gene encoding the protein tyrosine kinase Btk are associated with the human B cell immunodeficiency X-linked agammaglobulinemia (XLA). In the mouse, a point mutation in the Btk pleckstrin homology domain segregates with a milder X-linked immunodeficiency (xid). To assess the importance of Btk function in murine lymphopoiesis, we generated multiple embryonic stem cell clones bearing a targeted disruption of the btk gene and examined their potential to produce lymphocytes in both C57BL/6 and RAG2-/- host chimeric animals. These mice provide a complementary set of in vivo competition assays that formally establish the genetic basis for the xid phenotype. Although the null mutation yields a phenotype quite similar to that of xid, it also compromises expansion of B cell precursors. Our results suggest that the murine and human consequences of Btk deficiency differ only quantitatively, and represent the same disease process.
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
March 1997,
International immunology,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
January 2020,
Frontiers in immunology,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
December 2000,
The Journal of experimental medicine,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
January 2021,
Frontiers in immunology,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
November 2013,
The Journal of biological chemistry,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
May 1999,
Immunology letters,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
April 2019,
Science (New York, N.Y.),
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
February 2023,
Clinical advances in hematology & oncology : H&O,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
January 2001,
Advances in immunology,
J D Kerner, and
M W Appleby, and
R N Mohr, and
S Chien, and
D J Rawlings, and
C R Maliszewski, and
O N Witte, and
R M Perlmutter
September 1999,
Molecular and cellular biology,
